Gritstone bio to Participate in Upcoming Investor Conferences
05 9월 2023 - 8:00PM
Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology
company working to develop the world’s most potent vaccines, today
announced that management will be participating in the following
investor conferences:
2023 Wells Fargo Healthcare Conference (1x1s
only)Conference Dates: September 6 - 8,
2023Location: Boston, MA
H.C. Wainwright 25th Annual Global Investment Conference
(Fireside Chat)Presentation Date and Time: Wednesday,
September 13, 2023 at 11:30am ETSpeaker: Andrew Allen, M.D.,
Ph.D., Co-founder, President and Chief Executive
OfficerLocation: New York, NYWebcast:
https://journey.ct.events/view/c4f73a16-a091-4f5c-acf7-52adfe784529
Cantor Global Healthcare Conference (Fireside
Chat)Presentation Date and Time: Thursday, September
28, 2023 at 2:25pm ETSpeaker: Andrew Allen, M.D., Ph.D.,
Co-founder, President and Chief Executive OfficerLocation: New
York, NYWebcast: https://wsw.com/webcast/cantor19/grts/2121504
JonesTrading 2023 Healthcare Summit (1x1s
only)Conference Dates: October 9 - 11,
2023Location: Miami, FL
BIO Investor Forum (Panel Participation)Panel
Title: Extending RNA Technology Pipelines into New Tissues and
ApplicationsPanel Date and Time: Tuesday, October 17, 2023
from 3:00 to 3:50pm PTSpeaker: Andrew Allen, M.D., Ph.D.,
Co-founder, President and Chief Executive OfficerLocation: San
Francisco, CA
The live webcasts will also be available via
https://ir.gritstonebio.com/investors/events. Archived replays will
be accessible for 30 days following the event.
About Gritstone bioGritstone bio, Inc. (Nasdaq:
GRTS) is a clinical-stage biotechnology company that aims to
develop the world’s most potent vaccines. We leverage our
innovative vectors and payloads to train multiple arms of the
immune system to attack critical disease targets. Independently and
with our collaborators, we are advancing a portfolio of product
candidates to treat and prevent viral diseases and solid tumors in
pursuit of improving patient outcomes and eliminating disease.
www.gritstonebio.com
Gritstone ContactsInvestors:George E.
MacDougallGritstone bio, Inc.ir@gritstone.com
Media:Dan Budwick1AB(973) 271-6085dan@1abmedia.com
Gritstone bio (NASDAQ:GRTS)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Gritstone bio (NASDAQ:GRTS)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024